The nicotine pouch category is evolving rapidly across global markets, driven by regulatory shifts, growing consumer adoption, and strategic investment from major industry players. At GINN, we are building an AI-powered monitoring system designed to track global nicotine and oral product developments with greater speed, accuracy, and relevance. The concept is simple: AI scans hundreds…
Comparative analysis across jurisdictions can provide valuable insight into how regulatory frameworks influence public health outcomes. A recent report examining Argentina and Sweden highlights how differing approaches to nicotine regulation are associated with contrasting trends in smoking prevalence and disease burden. While both countries have implemented traditional tobacco control measures, their treatment of non-combustible nicotine…
Building on our initial look at the Commission’s TPD evaluation, the Tobacco Advertising Directive (TAD) is now being reframed to treat all nicotine products—traditional or novel—as part of a single regulatory category. The emphasis is shifting from differentiated risk communication to a comprehensive, product‑agnostic ban on advertising, promotion, and sponsorship. 📑 Key Shifts in Policy…
The Commission’s evaluation of the Tobacco Products Directive (TPD) 🎯 substantially overstates its public‑health success and fails to provide a credible evidence base for risk‑proportionate regulation of low‑risk nicotine products. 🔍 Framing & Methodology • Smoking prevalence reduction is treated as the main success metric, yet the evaluation does not convincingly isolate the TPD’s impact…
Comparative public health outcomes across countries can provide valuable insight into how regulatory frameworks shape behaviour, risk exposure, and long-term disease burden. A recent comparative analysis of Brazil and New Zealand highlights how differing policy approaches toward nicotine products are associated with divergent trends in smoking prevalence. Both countries have implemented strong tobacco control measures…
Ireland’s upcoming Presidency of the Council of the European Union presents a strategic opportunity to shape Europe’s public health agenda at a time of growing pressure on health systems and widening inequalities in outcomes. Recent discussions highlight a clear direction: stronger coordination, a renewed focus on prevention, and the need to address high-burden diseases through…
New U.S. evidence highlights patterns relevant to harm reduction policy As nicotine pouches (ONPs) continue to expand in the United States, understanding how adult smokers engage with these products is becoming increasingly important for evidence-based regulation. A recent peer-reviewed study using nationally representative data from the Population Assessment of Tobacco and Health (PATH) Study provides…
A productive and timely discussion in Vilnius with a European Parliament delegation led by Auke Zijlstra, MEP & Sebastian Kruis, MEP, Wilson George Group, NOIS Nicotine Pouches, Johan Nissinen, Glick®, Chubby Gorilla®, Inc., Adam Gambrill,Tautvydas Kviliunas and Andrius Miskelevicius on the evolving regulatory landscape for nicotine pouches across the Baltics and Europe. At the recent…
Across the European Union, tobacco control policy has historically focused on reducing smoking through restrictions, taxation, and public health campaigns. These measures have contributed to steady declines in smoking prevalence over time. However, the pace of change has varied across Member States, and smoking remains a significant public health concern. Within this broader context, Sweden…
European Union regulatory frameworks are designed to provide stability, predictability, and coherence across Member States. Directives such as the Tobacco Products Directive (TPD) and the Tobacco Excise Directive (TED) are central to this approach, establishing the rules that govern how tobacco and nicotine products are regulated and taxed across the internal market. These frameworks are…